Evotec
Alberto Perez is a Senior Research Scientist at Evotec since March 2021, bringing extensive experience in research and development. Prior to this role, Alberto served as a Senior Research Scientist and Senior Postdoctoral Fellow at Universitätsklinikum Hamburg Eppendorf from January 2013 to December 2020. Alberto's early career includes a position as a Postdoctoral Research Scientist at Instituto Cajal, CSIC from June 2011 to December 2012, and as a Research Assistant at Universidad Autónoma de Madrid from November 2004 to May 2011. Alberto holds a Doctor of Philosophy (PhD) degree from Universidad Autónoma de Madrid, completed in 2010, and a Master's degree in Pharmacy from Universidad de Santiago de Compostela, awarded in 2004.
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.